For the secretory PLA2s, there was no difference in the percentage of MCs expressing either sPLA2-IIA (Non-IBD 71.0% (52.3–74.1); CD 69.0 (48.5–73.5)) or sPLA2-V (Non-IBD 37.0 (25.5–57.5); CD 50.0 (30.0–50.1)). Here, PLA2G2A is linked to inflammatory bowel disease.